Vanguard Group’s Theriva Biologics TOVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-194,494
| Closed | -$46K | – | 4385 |
|
|
2024
Q2 | $46K | Sell |
194,494
-30,777
| -14% | -$7.27K | ﹤0.01% | 4297 |
|
|
2024
Q1 | $106K | Sell |
225,271
-141,309
| -39% | -$66.3K | ﹤0.01% | 4238 |
|
|
2023
Q4 | $158K | Sell |
366,580
-146,183
| -29% | -$62.9K | ﹤0.01% | 4252 |
|
|
2023
Q3 | $277K | Sell |
512,763
-12,604
| -2% | -$6.8K | ﹤0.01% | 4198 |
|
|
2023
Q2 | $525K | Hold |
525,367
| – | – | ﹤0.01% | 4109 |
|
|
2023
Q1 | $367K | Hold |
525,367
| – | – | ﹤0.01% | 4203 |
|
|
2022
Q4 | $239K | Buy |
525,367
+282
| +0.1% | +$128 | ﹤0.01% | 4275 |
|
|
2022
Q3 | $518K | Sell |
525,085
-4,771,416
| -90% | -$4.71M | ﹤0.01% | 4200 |
|
|
2022
Q2 | $1.13M | Hold |
5,296,501
| – | – | ﹤0.01% | 4044 |
|
|
2022
Q1 | $1.51M | Buy |
5,296,501
+48,102
| +0.9% | +$13.7K | ﹤0.01% | 4069 |
|
|
2021
Q4 | $1.43M | Buy |
5,248,399
+3,233,601
| +160% | +$880K | ﹤0.01% | 4159 |
|
|
2021
Q3 | $925K | Hold |
2,014,798
| – | – | ﹤0.01% | 4262 |
|
|
2021
Q2 | $1.21M | Hold |
2,014,798
| – | – | ﹤0.01% | 4115 |
|
|
2021
Q1 | $1.37M | Buy |
2,014,798
+1,978,404
| +5,436% | +$1.35M | ﹤0.01% | 3939 |
|
|
2020
Q4 | $14K | Sell |
36,394
-87,000
| -71% | -$33.5K | ﹤0.01% | 4201 |
|
|
2020
Q3 | $59K | Buy |
123,394
+105,248
| +580% | +$50.3K | ﹤0.01% | 4057 |
|
|
2020
Q2 | $9K | Hold |
18,146
| – | – | ﹤0.01% | 4072 |
|
|
2020
Q1 | $6K | Hold |
18,146
| – | – | ﹤0.01% | 4078 |
|
|
2019
Q4 | $9K | Hold |
18,146
| – | – | ﹤0.01% | 4117 |
|
|
2019
Q3 | $8K | Hold |
18,146
| – | – | ﹤0.01% | 4147 |
|
|
2019
Q2 | $10K | Sell |
18,146
-39,086
| -68% | -$21.5K | ﹤0.01% | 4163 |
|
|
2019
Q1 | $39K | Buy |
57,232
+16,251
| +40% | +$11.1K | ﹤0.01% | 4076 |
|
|
2018
Q4 | $23K | Sell |
40,981
-94,324
| -70% | -$52.9K | ﹤0.01% | 4114 |
|
|
2018
Q3 | $352K | Sell |
135,305
-4,536,169
| -97% | -$11.8M | ﹤0.01% | 3908 |
|
|
2018
Q2 | $1.12M | Buy |
4,671,474
+5,000
| +0.1% | +$1.19K | ﹤0.01% | 3657 |
|
|
2018
Q1 | $1.49M | Buy |
4,666,474
+73,341
| +2% | +$23.4K | ﹤0.01% | 3551 |
|
|
2017
Q4 | $2.33M | Buy |
4,593,133
+55,551
| +1% | +$28.2K | ﹤0.01% | 3377 |
|
|
2017
Q3 | $4.23M | Buy |
4,537,582
+182,348
| +4% | +$170K | ﹤0.01% | 3176 |
|
|
2017
Q2 | $2.46M | Sell |
4,355,234
-74,235
| -2% | -$42K | ﹤0.01% | 3325 |
|
|
2017
Q1 | $2.79M | Buy |
4,429,469
+2,623,816
| +145% | +$1.66M | ﹤0.01% | 3271 |
|
|
2016
Q4 | $1.38M | Sell |
1,805,653
-967,082
| -35% | -$738K | ﹤0.01% | 3481 |
|
|
2016
Q3 | $4.77M | Buy |
2,772,735
+11,541
| +0.4% | +$19.9K | ﹤0.01% | 3035 |
|
|
2016
Q2 | $4.97M | Buy |
2,761,194
+262,551
| +11% | +$473K | ﹤0.01% | 2987 |
|
|
2016
Q1 | $5.9M | Buy |
2,498,643
+70,150
| +3% | +$166K | ﹤0.01% | 2877 |
|
|
2015
Q4 | $5.56M | Buy |
2,428,493
+51,972
| +2% | +$119K | ﹤0.01% | 2942 |
|
|
2015
Q3 | $5.39M | Buy |
2,376,521
+417,854
| +21% | +$948K | ﹤0.01% | 2929 |
|
|
2015
Q2 | $5.58M | Buy |
1,958,667
+105,574
| +6% | +$301K | ﹤0.01% | 2959 |
|
|
2015
Q1 | $4.06M | Buy |
1,853,093
+469,054
| +34% | +$1.03M | ﹤0.01% | 3097 |
|
|
2014
Q4 | $2.02M | Buy |
1,384,039
+44,950
| +3% | +$65.6K | ﹤0.01% | 3286 |
|
|
2014
Q3 | $2.38M | Buy |
1,339,089
+153,574
| +13% | +$273K | ﹤0.01% | 3194 |
|
|
2014
Q2 | $2.04M | Hold |
1,185,515
| – | – | ﹤0.01% | 3258 |
|
|
2014
Q1 | $3.05M | Buy |
1,185,515
+419,175
| +55% | +$1.08M | ﹤0.01% | 3046 |
|
|
2013
Q4 | $1.17M | Buy |
766,340
+274,276
| +56% | +$420K | ﹤0.01% | 3370 |
|
|
2013
Q3 | $827K | Buy |
492,064
+164,104
| +50% | +$276K | ﹤0.01% | 3422 |
|
|
2013
Q2 | $564K | Buy |
+327,960
| New | +$564K | ﹤0.01% | 3444 |
|